The global leukocyte adhesion deficiency management market is treating leukocyte adhesion deficit is anticipated to reach a size of US$ 8.09 billion in 2023 and US$ 15.2 billion by 2033. Over the projected period of 2023–2033, the market is anticipated to grow at a CAGR of 6.51%. For instance, according to an article published by National Institute …
Category Archives: Healthcare Trends
Urinary Retention Therapeutics Market is likely to register CAGR of 8.11% 2033
The global urinary retention therapeutics market size is anticipated to attain an impressive valuation of USD 3.44 billion in 2023 and is projected to reach US$ 7.5 billion by 2033, expected to register a CAGR of 8.11% until 2033, as per a recently published Future Market Insights study. The market is anticipated to be fuelled …
Continue reading “Urinary Retention Therapeutics Market is likely to register CAGR of 8.11% 2033”
Venous Ulcer Treatment Market is expected to reach US$ 7.61 billion by 2033
The global venous ulcer treatment market is predicted to be worth US$ 2.96 billion in 2023, with a compound annual growth rate (CAGR) of 6.5% from 2023 to 2033. The market is expected to reach US$ 7.61 billion by the end of the forecast period. As per the NHS, venous ulcers are the most frequent …
Continue reading “Venous Ulcer Treatment Market is expected to reach US$ 7.61 billion by 2033”
Autosomal Dominant Polycystic Kidney Disease Treatment Market to expand at a 5.97% value CAGR by 2033
A recently published study by Future Market Insights predicts that the global autosomal dominant polycystic kidney disease treatment market will experience a value CAGR of 5.97% from 2023 to 2033, reaching an estimated value of US$ 2,140 million. The availability of special regulatory designations is one of the main drivers behind the market’s growth, with …
Low-Grade Glioma Therapeutics Market is expected to reach US$ 1515.47 Million by 2033, at a CAGR 4.57%
During the forecast period 2023 to 2033, the Low-grade Glioma therapeutics market is expected to grow at a value of 4.57% CAGR, according to Future Market Insights. By the year 2033, the global market for Low-grade Glioma therapeutics is expected to rise up to a market valuation of US$ 1515.47 Million. Growth of the market …
Gene Therapy in CNS Disorder Market is expected to reach US$ 113.04 Billion, at a CAGR 30%
The global gene therapy in CNS disorders market is predicted to generate a market value of US$ 8.2 billion in 2023 and a market value of US$ 113.04 billion by 2033, with a CAGR of 30% from 2023 to 2033. In the historical period 2018 to 2022, the market for gene therapy in CNS illnesses …
Medical Protective Equipment Market is expected to reach US$ 52.8 billion in 2033
The global medical protective equipment market is predicted to register a CAGR of 9.5% over the forecast period, according to FMI’s analysis. The industry’s value is anticipated to increase from US$ 21.3 billion in 2023 to US$ 52.8 billion by 2033 end. The medical protective equipment market is being driven by the surging demand from healthcare facilities. Key players in the market have …
Continue reading “Medical Protective Equipment Market is expected to reach US$ 52.8 billion in 2033”
Canine Atopic Dermatitis Treatment Market surging at an impressive CAGR of 12.3% from 2022 to 2029
[Report of 213 Pages] By the end of 2029, the market for canine atopic dermatitis treatment is anticipated to reach more than US$ 2.37 billion. The market is anticipated to grow as more emphasis is placed on the creation of novel therapeutics like monoclonal antibodies for the treatment of atopic dermatitis in dogs and cats. Attribute …
Magnetic Resonance Imaging (MRI) Contrast Agents industry will record sales worth U.S. $ 1.23 Billion by the end of 2029
[240 Page Document] In 2021, sales of magnetic resonance imaging (MRI) contrast agents reached a total value of US$ 871.0 Mn. Over the forecast period of 2022-2029, the market is anticipated to grow by 1.3X. By the end of 2029, the sector will have generated US$1.23 billion in sales. A recent market study published by Future Market …
Lacrimal Devices Market is expected to reach US$ 39.7 Million by the end of 2029
The lacrimal devices market is expected to reach US$ 39.7 million by the end of 2029, with sales revenue expected to register 5.5% CAGR. The Global Lacrimal Devices market growth is predicted to expand at a 5.5% compound annual growth rate (CAGR), with a market value of roughly US$ 25.6 million in 2021. Lacrimal devices like Nasolacrimal stents are small tubes …
Continue reading “Lacrimal Devices Market is expected to reach US$ 39.7 Million by the end of 2029”